FDA clears repurposed GSK drug for ultra-rare brain disease instead of autism
FDA clears repurposed GSK drug for ultra-rare brain disease instead of autism
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.
FDA clears repurposed GSK drug for ultra-rare brain disease instead of autism
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.